Anon.: Drug Interactions That Can Affect Your Patients, Patient Care1: 32 (Nov.) 1967. (R).
3.
Anon.: Drug Interactions, Ill. Pharmacist33: 336 (July) 1969. (R).
4.
American Hospital Formulary Service, American Society of Hospital Pharmacists, Washington, D. C., (R).
5.
BarakaA.: Effect of Halothane on Tubocurarine and Suxamethonium Block in Man, Brit. J. Anaesthesia40: 602 (Aug.) 1968. (OH).
6.
Blake-KnoxP. E. A.: Neuromuscular Block with Streptomycin, Brit. Med. J.1: 1319, 1961. (CH).
7.
Bristol Laboratories Product Brochure: Kanamycin Sulfate Injection, October 1967. (R).
8.
BurnsJ. J.ConneyA. H.: Enzyme Stimulation and Inhibition in the Metabolism of Drugs, Proc. Roy. Soc. Med.58: 955 (Nov.) 1965. (R).
9.
BushG. H.: Prolonged Neuromuscular Block Due to Intraperitoneal Streptomycin, Brit. Med. J.1: 557 (Feb. 25) 1961. (CH).
10.
ChasapakisG.DimasC.: Possible Interaction Between Muscle Relaxants and the Kallikrein-Trypsin In-activator “Trasylol”: Report of Three Cases, Brit. J. Anaesthesia38: 838 (Oct.) 1966. (CH).
CrossF. C.CanadaA. T.Jr.DavisN. M.: The Effect of Certain Drugs on the Results of Some Common Laboratory Diagnostic Procedures, Am. J. Hosp. Pharm.23: 234 (May) 1966. (R).
13.
CuthbertM. F.: The Effect of Quinidine and Procainamide on the Neuromuscular Blocking Action of Suxamethonium, Brit. J. Anaesthesia38: 775–9 (Oct.) 1966. (OA).
14.
DunphyT. W.: The Role of the Pharmacist in the Prevention of Adverse Drug Interactions, Am. J. Hosp. Pharm.26: 366 (July) 1969. (R).
15.
ElkingM. P.Sr.RabatH. F.: Drug Induced Modifications of Laboratory Test Values, Am. J. Hosp. Pharm.25: 845 (Sept.) 1968. (R).
16.
EllenhornM. J.SternadF. A.: Problems of Drug Interactions, J. Am. Pharm. Assoc.NS6: 62 (Jan.) 1966. (R).
17.
FiskG. C.: Respiratory Paralysis After a Large Dose of Streptomycin, Brit. Med. J.1: 556 (Feb. 25) 1961. (CH).
18.
FoldesF. F.LunnJ. N.BenzH. G.: Prolonged Respiratory Depression Caused by Drug Combinations. Muscle Relaxants and Intraperitoneal Antibiotics as Etiologic Agents, J. Am. Med. Assoc.183: 672 (Feb. 23) 1963. (CH).
19.
FormanD. T.: Effect of Variables on Chemical and Diagnostic Specificity of Laboratory Tests, Memo to Attending Staff, Evanston Hospital. (R).
20.
FosterP.: Potassium Depletion and the Central Action of Curare, Brit. J. Anaesthesia28: 488 (Nov.) 1956. (CH).
21.
FreemonF. R.ParkerR. L.Jr.GreerM.: Unusual Neurotoxicity of Kanamycin, J. Am. Med. Assoc.200: 410 (May 1) 1967. (CH).
22.
GoodmanL. S.GilmanA.: The Pharmacological Basis of Therapeutics, 3rd Edition, New York, 1965, Macmillan Co. (R).
23.
HussarD. A.: Therapeutic Incompatibilities: Drug Interactions, Am. J. Pharm.139: 215 (Nov.-Dec.) 1967. (R).
24.
LindesmithL. A.: Reversible Respiratory Paralysis Associated with Polymyxin Therapy, Ann. Internal Med.68: 318 (Feb.) 1968.
McIverA. K.: Drug Interactions, Pharm. J.199: 205, 1967. (R).
27.
MillerR. D.WayW. L.KatzungB. G.: The Potentiation of Neuromuscular Blocking Agents by Quinidine, Anesthesiology28: 1036 (Nov.-Dec.) 1967. (OA).
28.
MorrelliH. F.MelmonK. L.: The Clinician's Approach to Drug Interactions, Calif. Med.109: 380 (Nov.) 1968. (R).
29.
McGaviD. D. Murray: Depressed Levels of Serum-Pseudocholinesterase with Ecothiophate-Iodine Eye Drops, Lancet2: 272 (Aug. 7) 1965. (OH).
30.
SchmidtJ. L.: The Effect of Quinidine on the Action of Muscle Relaxants, J. Am. Med. Assoc.183: 669 (Feb. 23) 1963. (CH, OA).
31.
SikhS. S.SachdevK. S.: Duration of the Neuromuscular Blocking Action of Streptomycin, Brit. J. Anaesthesia37: 158 (Mar.) 1965. (OA).
32.
StuartD. M.: Drug Metabolism, Part II-Drug Interactions, Pharmindex10: 4 (Oct.) 1968. (R).
33.
TrubuhovichR. V.: Delayed Reversal of Diallyl-Nortoxiferine after Streptomycin, Brit. J. Anaesthesia38: 843–44 (Oct.) 1966. (CH).
34.
Upjohn Company, Product Brochure, Neomycin Sulfate, June 1968.
35.
WayW. L.KatzungB. G.LarsonC. P.Jr.: Recurarization with Quinidine, J. Am. Med. Assoc.200: 153 (Apr. 10) 1967. (CH) Pertinent References NOT Reviewed By Author.
36.
BrienzaA.: Prolungamento del blocco neuromuscular du curarizz anti per azione di antibiotics, Rass. Int. Clin. Ter.46/20: 1081, 1966.
37.
CheymolJ.Van Den DriesscheJ.AllainP.Eben-MoussiE.: [Propanidid and Curarization]Therapie23: 793–804 (July-Aug.) 1968.
38.
ConneyA. H.BurnsJ. J.: Biochemical Pharmacological Considerations of Zoxazolamine and Chlorzoxazone Metabolism, Ann. New York Acad. Sci.86: 167 (Mar.) 1960.
39.
ConneyA. H.: Adaptive Increases in Drug-Metabolizing Enzymes Induced by Phenobarbital and Other Drugs, J. Pharmacol. Exptl. Therap.130: 1 (Sept.) 1960.
40.
ConneyA. H.MichaelsonI. A.BurnsJ. J.: Stimulatory Effect of Chlorcyclizin on Barbiturate Metabolism, Ibid.132: 202 (May) 1961.
41.
GrosshandlerS. L.HenschelE. O.KampineJ. P.: Toxic Reactions Due to Drug Synergism and Antagonism, Anesthesia Analgesia, Current Res.47: 345–349 (July-Aug.) 1968.
42.
JurjerJ. N.KiryakinaG. K.JrkouA. D.: A Prolonged Apnea Induced by the Use of Large Doses of Antibiotics in Operative Regional Perfusion of the Extremity, Vestn. Khir. Grekor98/3: 130, 1967.
43.
KatoR.ChiesaraE.: Increase of Pentobarbitone Metabolism Induced in Rats Pretreated with Some Centrally Acting Compounds, Brit. J. Pharmacol.18: 29 (Feb.) 1962.
44.
KatoR.VassanelliP.: Induction of Increased Meprobamate Metabolism in Rats Pretreated with some Neurotropic Drugs, Biochem. Pharmacol.11: 779 (Aug.) 1962.
45.
KatoR.ChiesaraE.VassanelliP.: Further Studies on the Inhibition and Stimulation of Microsomal Drug-Metabolizing Enzymes of Rat Liver by Various Compounds, Biochem. Pharmacol.13: 69 (Jan.) 1964.
46.
McQuillenM. P.CantorH. E.O'RourkeJ. R.: Myasthenic Syndrome Associated with Antibiotics, Arch. Neurol.18: 402 (Apr.) 1968.
47.
PinkertonH. H.MunroJ. R.: Respiratory Insufficiency Associated with the Use of Streptomycin, Scot. Med. J.9: 256 (June) 1964.
48.
PittingerC. B.: The Choice and Mode of Administration of Relaxants, (6.) Antagonists of Muscle Relaxants, Clin. Anesthesia2: 95–119, 1966.
49.
ReganA. G.AldreteJ. A.: Prolonged Apnea After Administration of Promazine Hydrochloride Following Succinylcholine Infusion: A Case Report, Anesthesia Analgesia Current Res.46: 315–8 (May-June) 1967.
50.
SmithN. T.WhitcherC. E.: Hemodynamic Effects of Gallamine and Tubocurarine Administered During Halothane Anesthesia, J. Am. Med. Assoc.199: 704 (Mar. 6) 1967.
51.
UsubiagaJ. E.WikinskiJ. A.UsubiagaL. E.MolinaF.: Intravenous Lidocaine in the Prevention of Postoperative Muscle Pain Caused by Succinylcholine Administration, Anesthesia Analgesia Current Res.46: 225–30 (Mar.-Apr.) 1967.
52.
UsubiagaJ. E.WikinskiJ. A.MoralesR. L.: Interaction of Intravenously Administered Procaine, Lidocaine, and Succinylcholine in Anesthetized Subjects, Ibid.46: 39–45 (Jan.-Feb.) 1967.
53.
ViljocnJ. F.: Parenteral Neomycin and Muscle Relaxants. Two Case Reports of Interest, S. African Med. J., 40/39: 936, 1966.
54.
BrazilO. VitalCorradoA. P.: The Curariform Action of Streptomycin, J. Pharmacol. Exptl. Therap.120: 452 (Aug.) 1957.
55.
WeillM. J.Gauthier-LafayeP.DupuisJ.: Curarizing Action of Antibiotics and Potentiation of Curare by Antibiotics, Therapie23: 879–884 (July-Aug.) 1968.
56.
BirchA. A.Jr.: Changes in Serum Potassium Response to Succinylcholine Following Trauma, J. Am. Med. Assoc.210: 490 (Oct. 20) 1969.
57.
Anon., (Ed.): Succinylcholine and Trauma, Ibid.210: 549 (Oct. 20) 1969.